Black Bird Biotech, Inc.
BBBT
$0.00
$0.000.00%
OTC PK
| 09/30/2023 | 06/30/2023 | 03/31/2023 | 12/31/2022 | 09/30/2022 | |
|---|---|---|---|---|---|
| Revenue | 36.30K | 58.10K | 76.10K | 82.50K | 93.00K |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.30K | 58.10K | 76.10K | 82.50K | 93.00K |
| Cost of Revenue | 49.50K | 59.40K | 72.20K | 88.90K | 53.70K |
| Gross Profit | -13.30K | -1.30K | 4.00K | -6.30K | 39.40K |
| SG&A Expenses | 296.90K | 455.10K | 814.80K | 1.19M | 1.74M |
| Depreciation & Amortization | 4.40K | 25.50K | 57.20K | 88.90K | 120.50K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 351.00K | 540.20K | 944.30K | 1.37M | 1.91M |
| Operating Income | -314.70K | -482.10K | -868.20K | -1.29M | -1.82M |
| Income Before Tax | -836.10K | -929.70K | -1.26M | -1.66M | -2.30M |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -0.84 | -0.93 | -1.26 | -1.66 | -2.30 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -836.10K | -929.70K | -1.26M | -1.66M | -2.30M |
| EBIT | -314.70K | -482.10K | -868.20K | -1.29M | -1.82M |
| EBITDA | -26.00K | -223.60K | -653.20K | -1.20M | -1.70M |
| EPS Basic | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Basic EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| EPS Diluted | 0.00 | 0.00 | 0.00 | -0.01 | -0.01 |
| Normalized Diluted EPS | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Average Basic Shares Outstanding | 2.94B | 1.78B | 1.46B | 1.32B | 1.17B |
| Average Diluted Shares Outstanding | 3.87B | 2.28B | 1.52B | 1.43B | 1.27B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |